Tapinarof Cream Effective For Patients With Plaque Psoriasis
Medical Dialogues
English - December 14, 2021 11:40 - 1 minute - 1.34 MBMedicine Health & Fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Lupus a Harmful Trigger For Macular Degeneration
Next Episode: Severe COVID could Reduce Male Fertility
Tapinarof cream is a topical aryl hydrocarbon receptor–modulating agent under investigation for psoriasis treatment. Tapinarof modulates the expression of interleukin-17 and the skin-barrier proteins filaggrin and loricrin. Mark G. Lebwoh and the team conducted two identical phase 3 randomized trials of tapinarof in patients with mild-to-severe plaque psoriasis.